Location History:
- Omiya, JP (2000 - 2001)
- Tokyo, JP (2001)
- Minamisaitama-gun, JP (2012 - 2013)
- Saitama, JP (2012 - 2015)
- Yoshikawa, JP (2013 - 2022)
Company Filing History:
8 out of 314 
8 out of 90,753 
3 out of 107 
Years Active: 2000-2025
Title: The Innovations of Tomohiro Sugimoto
Introduction
Tomohiro Sugimoto is a prominent inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing macrolide compounds. With a total of 16 patents to his name, Sugimoto's work has been instrumental in addressing antibiotic resistance.
Latest Patents
Among his latest patents is the "C-4″ position substituted macrolide derivative." This macrolide compound is effective against erythromycin-resistant bacteria, including resistant pneumococci, streptococci, and mycoplasmas. Another notable patent is the "10a-azalide compound having a 4-membered ring structure." This compound features a 4-membered ring structure crosslinked at the 10- and 12-positions, making it effective against erythromycin-resistant bacteria as well.
Career Highlights
Throughout his career, Sugimoto has worked with reputable companies such as Taisho Pharmaceutical Co., Ltd. and Meiji Seika Pharma Co., Ltd. His innovative research and development efforts have contributed to advancements in antibiotic therapies.
Collaborations
Some of his notable coworkers include Masato Kashimura and Kanako Yamamoto. Their collaborative efforts have further enhanced the impact of Sugimoto's inventions in the pharmaceutical industry.
Conclusion
Tomohiro Sugimoto's contributions to the field of pharmaceuticals through his innovative patents highlight the importance of addressing antibiotic resistance. His work continues to influence the development of effective treatments for resistant bacterial infections.